Last reviewed · How we verify

NCT03085576: NATURE-AF

NATional TUnisian REgistry of Atrial Fibrillation

Completed Last updated 29 April 2021
What this trial tests

trial in Atrial Fibrillation in 910 participants. Completed in 30 July 2018.

Timeline
1 March 2017
Primary endpoint
30 May 2018
30 July 2018

Quick facts

Lead sponsorDacima Consulting
StatusCompleted
Study typeOBSERVATIONAL
Enrollment910
Start date1 March 2017
Primary completion30 May 2018
Estimated completion30 July 2018
Sites1 location across Tunisia

Conditions studied

Sponsor

Dacima Consulting

Who can join

20 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A non-interventional, national longitudinal study of atrial fibrillation performed with 91 cardiologists.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Design and Rationale of the National Tunisian Registry of Atrial Fibrillation: Protocol for a Prospective, Multicenter Trial.
    Ben Halima A, Ouali S, Mourali MS, Chabrak S, et al · · 2018 · cited 2× · PMID 30322836 · DOI 10.2196/resprot.8523

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Dacima Consulting trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03085576.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing